539 related articles for article (PubMed ID: 7871904)
1. [Antinuclear antibodies in rheumatology].
Zuber M
Z Rheumatol; 1994; 53(6):327-34. PubMed ID: 7871904
[TBL] [Abstract][Full Text] [Related]
2. The clinical significance of antinuclear antibodies in connective tissue disease.
Pahor A; Krajnc I; Gorenjak M; Holc I
Wien Klin Wochenschr; 1998 May; 110(9):338-41. PubMed ID: 9629626
[TBL] [Abstract][Full Text] [Related]
3. [Sharp's syndrome. Clinical, immunological and nosographic aspects].
Scagliusi P; Muratore M; Martiradonna A; Berlingerio G; Carrozzo M
Minerva Med; 1980 Dec; 71(50):3655-63. PubMed ID: 6161325
[TBL] [Abstract][Full Text] [Related]
4. Antinuclear antibody detection by automated multiplex immunoassay in untreated patients at the time of diagnosis.
Op De Beéck K; Vermeersch P; Verschueren P; Westhovens R; Mariën G; Blockmans D; Bossuyt X
Autoimmun Rev; 2012 Dec; 12(2):137-43. PubMed ID: 22387973
[TBL] [Abstract][Full Text] [Related]
5. [Antinuclear antibodies in primary biliary cirrhosis].
Mzali S; Johanet C; Chrétien P; Abuaf N
Gastroenterol Clin Biol; 1989; 13(8-9):690-5. PubMed ID: 2680726
[TBL] [Abstract][Full Text] [Related]
6. Anti-telomere antibodies in systemic lupus erythematosus (SLE): a comparison with five antinuclear antibody assays in 430 patients with SLE and other rheumatic diseases.
Salonen EM; Miettinen A; Walle TK; Koskenmies S; Kere J; Julkunen H
Ann Rheum Dis; 2004 Oct; 63(10):1250-4. PubMed ID: 15361381
[TBL] [Abstract][Full Text] [Related]
7. Clinical and serological heterogeneity in patients with anticentromere antibodies.
Miyawaki S; Asanuma H; Nishiyama S; Yoshinaga Y
J Rheumatol; 2005 Aug; 32(8):1488-94. PubMed ID: 16078324
[TBL] [Abstract][Full Text] [Related]
8. Association of Immunofluorescence pattern of Antinuclear Antibody with Specific Autoantibodies in the Bangladeshi Population.
Sharmin S; Ahmed S; Abu Saleh A; Rahman F; Choudhury MR; Hassan MM
Bangladesh Med Res Counc Bull; 2014 Aug; 40(2):74-8. PubMed ID: 26415344
[TBL] [Abstract][Full Text] [Related]
9. Second generation analysis of antinuclear antibody (ANA) by combination of screening and confirmatory testing.
Scholz J; Grossmann K; Knütter I; Hiemann R; Sowa M; Röber N; Rödiger S; Schierack P; Reinhold D; Bogdanos DP; Meroni PL; Radice A; Conrad K; Roggenbuck D
Clin Chem Lab Med; 2015 Nov; 53(12):1991-2002. PubMed ID: 26020561
[TBL] [Abstract][Full Text] [Related]
10. Quantitative radioligand assays using de novo-synthesized recombinant autoantigens in connective tissue diseases: new tools to approach the pathogenic significance of anti-RNP antibodies in rheumatic diseases.
Yamamoto AM; Amoura Z; Johannet C; Jeronimo AL; Campos H; Koutouzov S; Piette JC; Bach JF
Arthritis Rheum; 2000 Mar; 43(3):689-98. PubMed ID: 10728764
[TBL] [Abstract][Full Text] [Related]
11. Update on autoantibodies to intracellular antigens in systemic rheumatic diseases.
Nakamura RM; Tan EM
Clin Lab Med; 1992 Mar; 12(1):1-23. PubMed ID: 1563236
[TBL] [Abstract][Full Text] [Related]
12. Clinical utility of common serum rheumatologic tests.
Lane SK; Gravel JW
Am Fam Physician; 2002 Mar; 65(6):1073-80. PubMed ID: 11925083
[TBL] [Abstract][Full Text] [Related]
13. Laboratory tests in the diagnosis and follow-up of pediatric rheumatic diseases: an update.
Breda L; Nozzi M; De Sanctis S; Chiarelli F
Semin Arthritis Rheum; 2010 Aug; 40(1):53-72. PubMed ID: 19246077
[TBL] [Abstract][Full Text] [Related]
14. [Comparison between line immunoassay (LIA) and enzyme-linked immunosorbent assay (ELISA) for the determination of antibodies to extractable nuclear antigenes (ENA) with reference to other laboratory results and clinical features].
Maclachlan D; Vogt P; Wu X; Rose L; Tyndall A; Hasler P
Z Rheumatol; 2002 Oct; 61(5):534-44. PubMed ID: 12399881
[TBL] [Abstract][Full Text] [Related]
15. Early undifferentiated connective tissue disease. II. The frequency of circulating antinuclear antibodies in patients with early rheumatic diseases.
Clegg DO; Williams HJ; Singer JZ; Steen VD; Schlegel S; Ziminski C; Alarcón GS; Luggen ME; Polisson RP; Willkens RF
J Rheumatol; 1991 Sep; 18(9):1340-3. PubMed ID: 1757935
[TBL] [Abstract][Full Text] [Related]
16. Presence of antinucleosome autoantibodies in a restricted set of connective tissue diseases: antinucleosome antibodies of the IgG3 subclass are markers of renal pathogenicity in systemic lupus erythematosus.
Amoura Z; Koutouzov S; Chabre H; Cacoub P; Amoura I; Musset L; Bach JF; Piette JC
Arthritis Rheum; 2000 Jan; 43(1):76-84. PubMed ID: 10643702
[TBL] [Abstract][Full Text] [Related]
17. Biological markers in inflammatory rheumatic diseases.
Hilliquin P
Cell Mol Biol (Noisy-le-grand); 1995 Dec; 41(8):993-1006. PubMed ID: 8747080
[TBL] [Abstract][Full Text] [Related]
18. Autoantibodies in the diagnosis of systemic rheumatic diseases.
von Mühlen CA; Tan EM
Semin Arthritis Rheum; 1995 Apr; 24(5):323-58. PubMed ID: 7604300
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of a novel line-blot immunoassay for the detection of antibodies to extractable nuclear antigens.
Damoiseaux J; Boesten K; Giesen J; Austen J; Tervaert JW
Ann N Y Acad Sci; 2005 Jun; 1050():340-7. PubMed ID: 16014550
[TBL] [Abstract][Full Text] [Related]
20. [Difficulties in differential diagnosis of Sjögren's syndrome and systemic lupus erythematosus].
Krawiec P; Batko B; Skura A; Adamek-Guzik T; Cześnikiewicz-Guzik M; Krzanowski M; Rydz-Stryszowska I; Ryszawa N; Guzik TJ
Przegl Lek; 2006; 63(5):278-83. PubMed ID: 17036505
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]